Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1000
-0.0130 (-11.50%)
Feb 6, 2026, 10:56 AM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 138.71 million as of February 6, 2026. Its market cap has decreased by -37.40% in one year.
Market Cap
138.71M
Enterprise Value
156.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 138.71M, a decrease of -81.92%. That is a compound annual growth rate of -44.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 138.71M | 20.99% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Genmab | 122.43B |
| Coloplast | 121.11B |
| ALK-Abelló | 47.38B |
| Gubra | 6.73B |
| BioPorto | 480.24M |
| ViroGates | 113.24M |
| Scandinavian Medical Solutions | 106.22M |